HOLON, Israel, May 1, 2023 /PRNewswire/ Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will. | May 1, 2023
HOLON, Israel, Feb. 13, 2023 /PRNewswire/ Compugen Ltd. , a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will. | February 13, 2023